Skip to main content

Table 3 Total counts and proportions of peripheral blood cells in patients with and without TCFA

From: Comparison of circulating dendritic cell and monocyte subsets at different stages of atherosclerosis: insights from optical coherence tomography

  Patients with TCFA (n = 20) Patients without TCFA (n = 28) p value
WBC, ×106/ml 6.88 ± 1.98 7.12 ± 1.98 0.690
PMN, % WBC 59.83 ± 9.45 61.33 ± 9.88 0.613
Lym, % WBC 32.75 ± 8.94 31.70 ± 9.87 0.717
PMN/Lym ratio 2.22 ± 1.69 2.29 ± 1.31 0.883
Mon, % WBC 5.83 ± 1.25 5.82 ± 1.41 0.989
mDC1s, % WBC 0.24 ± 0.05 0.21 ± 0.04 0.134
mDC2s, % WBC 1.08 × 10−2 ± 0.39 × 10−2 1.13 × 10−2 ± 0.44 × 10−2 0.664
mDCs, % WBC 0.25 ± 0.05 0.23 ± 0.05 0.151
pDCs, % WBC 0.15 ± 0.03 0.16 ± 0.03 0.285
mDC1s, ×104/ml 1.63 ± 0.61 1.57 ± 0.76 0.791
mDC2s, ×104/ml 0.08 ± 0.04 0.08 ± 0.05 0.605
mDCs, ×104/ml 1.71 ± 0.64 1.66 ± 0.79 0.825
pDCs, ×104/ml 1.07 ± 0.30 1.22 ± 0.41 0.173
Mon1, % monocytes 82.84 ± 6.17 82.02 ± 5.15 0.754
Mon2, % monocytes 11.96 ± 4.27 9.43 ± 5.15 0.035
Mon3, % monocytes 4.93 ± 3.22 8.43 ± 3.75 0.001
Mon1, ×105/ml 3.25 ± 0.96 3.52 ± 1.22 0.470
Mon2, ×104/ml 5.17 ± 1.92 3.53 ± 2.65 0.045
Mon3, ×104/ml 2.23 ± 1.44 3.66 ± 2.16 0.059
  1. Values are mean ± SD
  2. Abbreviations as Table 1 and Table 2. P-values of risk factors with significance are presented as italic form